{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:47:22Z","timestamp":1759229242133,"version":"3.41.2"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023751","name":"Idiap Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Patients living in nursing homes have increased aging, comorbidity, spending on health resources and mortality. High drug use is associated with an increased risk of falls, disability, and death. It is estimated that 20%\u201350% of inappropriate medications are consumed in the elderly.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This abstract outline the study protocol for evaluating the effectiveness of a pharmaceutical intervention designed to optimize medication use among nursing home residents, with a particular focus on reducing drug-related problems (DRPs) and minimizing polypharmacy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Hypothesis<\/jats:title><jats:p>The pharmaceutical intervention led by a primary care pharmacist and based on systematically reviewing the pharmacotherapeutic plans of patients admitted to nursing homes will effectively improve the quality and safety of treatment plans.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>Pre-post, quasi-experimental intervention study with a control group and prospective 3-month follow-up of a cohort of patients in nursing homes. The intervention consists of a clinical review of the pharmacotherapeutic plan carried out by the pharmacist and subsequently agreed upon in the pharmacotherapeutic advisory committee.<\/jats:p><\/jats:sec><jats:sec><jats:title>Determinations<\/jats:title><jats:p>The study variables will be evaluated at baseline and 3\u00a0months post-intervention. The outcome variables are drug-related problems and polymedication.<\/jats:p><\/jats:sec><jats:sec><jats:title>Statistical analysis<\/jats:title><jats:p>Percentage change will be measured before and after the intervention. Descriptive statistics will be performed for quantitative variables such as qualitative and comparison of means and proportions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Expected results<\/jats:title><jats:p>Decreasing 10% DRPs in terms of number of DRPs per patient as well as the proportion of patients experiencing DRPs. Reducing 10% polymedication in terms of the number of drugs per patient as well as the number of polymedicated patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Applicability and relevance<\/jats:title><jats:p>This study will expand the collaboration between the pharmacy and primary care physicians, promoting the continuum of care, strengthening the safety culture, and improving prescribing habits.<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics<\/jats:title><jats:p>The protocol was approved by the Research Ethics Committee of the Jordi Gol Primary Care Research Institute (IDIAP), Barcelona, 22\/191-EOm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration<\/jats:title><jats:p><jats:ext-link>clinicaltrials.gov<\/jats:ext-link>, NCT05944328 Registered.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1522650","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:34Z","timestamp":1752207034000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Effectiveness of a structured pharmaceutical review of pharmacotherapeutic plans to reduce drug-related problems in nursing homes: a study protocol of a pragmatic quasi-experimental trial"],"prefix":"10.3389","volume":"16","author":[{"given":"Cec\u00edlia","family":"Campabadal-Prats","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enric","family":"Aragon\u00e8s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Romeu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Salom-Garrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferran","family":"Bejarano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Mart\u00edn Luj\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Canadell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/jgs.15767","article-title":"American geriatrics society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"67","year":"2019","journal-title":"J. Am. Geriatr. Soc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00228-013-1562-0","article-title":"Negative clinical outcomes of medication resulting in emergency department visits","volume":"70","author":"Baena","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4321\/s1885-642x2006000300001","article-title":"Efectos de las intervenciones del farmac\u00e9utico en pacientes polimedicados","volume":"4","author":"Chumney","year":"2006","journal-title":"Pharm. Pract."},{"key":"B5","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40801-016-0061-x","article-title":"Drug-related problems identified in a sample of Portuguese institutionalised elderly patients and pharmacists\u2019 interventions to improve safety and effectiveness of medicines","volume":"3","author":"Costa","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"B6","doi-asserted-by":"publisher","first-page":"192","DOI":"10.7399\/fh.2015.39.4.8329","article-title":"Impacto de la Intervenci\u00f3n Farmac\u00e9utica en el tratamiento del paciente mayor pluripatol\u00f3gico","volume":"39","author":"Delgado-Silveira","year":"2015","journal-title":"Farm Hosp."},{"key":"B7","volume-title":"\u00das racional de medicaments: maneig b\u00e0sic de la medicaci\u00f3 en el pacient cr\u00f2nic: conciliaci\u00f3, revisi\u00f3, desprescripci\u00f3 i adher\u00e8ncia","year":"2013"},{"key":"B8","volume-title":"Programa de prevenci\u00f3 i atenci\u00f3 a la cronicitat (PPAC)","year":"2015"},{"key":"B9","article-title":"Bases per a un model catal\u00e0 d\u2019atenci\u00f3 a les persones amb necessitats complexes: conceptualitzaci\u00f3 i introducci\u00f3 als elements operatius","year":"2017","journal-title":"Dep. Salut"},{"key":"B10","volume-title":"Estrat\u00e8gia nacional d'atenci\u00f3 prim\u00e0ria i salut comunit\u00e0ria: enapisc","year":"2019"},{"key":"B11","first-page":"56","volume-title":"Polypharmacy and medicines optimisation: making it safe and sound","author":"Duerden","year":"2013"},{"key":"B12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.eurger.2015.07","article-title":"The EU(7)-PIM list: a list of potentially inappropriate medications for older people consented by experts from seven European countries","volume":"6","author":"Fick","year":"2015","journal-title":"Eur. Geriatr. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1471-2318-11-16","article-title":"Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials","volume":"11","author":"Forsetlund","year":"2011","journal-title":"BMC Geriatr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/s41598-020-80560-2","article-title":"Drug related problems in clinical practice: a cross-sectional study on their prevalence, risk factors and associated pharmaceutical interventions","volume":"11","author":"Garin","year":"2021","journal-title":"Sci. Rep."},{"key":"B15","volume-title":"Model Catal\u00e0 d\u2019Atenci\u00f3 Integrada. Cap a una atenci\u00f3 centrada en la persona","year":"2015"},{"key":"B16","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","article-title":"Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes","volume":"65","author":"Gnjidic","year":"2012","journal-title":"J. Clin. Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/archinte.166.6.605","article-title":"Reconsidering medication appropriateness for patients late in life","volume":"166","author":"Holmes","year":"2006","journal-title":"Arch. Intern Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3238\/arztebl.2010.0543","article-title":"Potentially inappropriate medications in the elderly: the PRISCUS list","volume":"107","author":"Holt","year":"2010","journal-title":"Dtsch. Arztebl Int."},{"key":"B19","volume-title":"Guia de bona pr\u00e0ctica en la recerca en ci\u00e8ncies de la salut de l'ICS","year":"2010"},{"key":"B20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jamda.2018.10.026","article-title":"Health outcomes of deprescribing interventions among older residents in nursing homes: a systematic review and meta-analysis","volume":"20","author":"Kua","year":"2019","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1111\/bcp.14101","article-title":"Pharmacist services in nursing homes: a systematic review and meta-analysis","volume":"85","author":"Lee","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1080\/14737167.2020.1707082","article-title":"Impact of pharmacist-led multidisciplinary medication review on the safety and medication cost of the elderly people living in a nursing home: a before-after study","volume":"20","author":"Leguelinel-Blache","year":"2020","journal-title":"Expert Rev. Pharmacoecon Outcomes Res."},{"key":"B23","first-page":"56","article-title":"Functional evaluation: the barthel index","volume":"14","author":"Mahoney","year":"1965","journal-title":"Md. State Med. J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0025-7753(01)72040-4","article-title":"Adaptaci\u00f3n y validaci\u00f3n al castellano del cuestionario de Pfeiffer (SPMSQ) para detectar la existencia de deterioro cognitivo en personas mayores de 65 a\u00f1os","volume":"117","author":"Mart\u00ednez de la Iglesia","year":"2001","journal-title":"Med. Clin. Barc."},{"key":"B25","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11096-017-0581-9","article-title":"The scope of drug-related problems in the home care setting","volume":"40","author":"Meyer-Massetti","year":"2018","journal-title":"Int. J. Clin. Pharm."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0252151","DOI":"10.1371\/journal.pone.0252151","article-title":"Pharmacist medication review: an integrated team approach to serve home-based primary care patients","volume":"16","author":"Monz\u00f3n-Kenneke","year":"2021","journal-title":"PLoS One"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsps.2013.05.006","article-title":"Systemic review on drug related hospital admissions \u2013 a PubMed based search","volume":"23","author":"Nivya","year":"2015","journal-title":"Saudi Pharm. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","article-title":"STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2","volume":"44","author":"O'Mahony","year":"2015","journal-title":"Age Ageing"},{"key":"B29","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1592\/phco.22.11.915.33630","article-title":"Drug-related visits to the emergency department: how big is the problem?","volume":"22","author":"Patel","year":"2002","journal-title":"Pharmacotherapy"},{"key":"B30","unstructured":"Research team\n          \n          \n            \n              Roth McClurg\n              M.\n            \n            \n              Vice Dean\n              E.\n            \n            \n              Sorensen\n              T. D.\n            \n            \n              Department Head\n              A.\n            \n            \n              Carroll\n              J.\n            \n            \n              Martin Blanchard\n              C.\n            \n          \n          \n          2024"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1016\/j.jamda.2021.05.038","article-title":"The impact of pharmaceutical care in multidisciplinary teams on health outcomes: systematic review and meta-analysis","volume":"22","author":"Ruiz-Ramos","year":"2021","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B32","article-title":"F\u00e0rmacs potencialment inapropiats per a persones d\u2019edat avan\u00e7ada","volume-title":"Ger\u00e8ncia del Medicament","year":"2020"},{"key":"B33","volume-title":"Posicionamiento SEFAP en la revisi\u00f3n de la medicaci\u00f3n centrada en la persona","year":"2022"},{"key":"B34","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semerg.2019.05.009","article-title":"Riesgo de ca\u00eddas y consumo de f\u00e1rmacos en los pacientes mayores de 65 a\u00f1os","volume":"45","author":"Tur\u00e9gano","year":"2019","journal-title":"Med. Fam. SEMERGEN"},{"key":"B35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4140\/TCP.n.2011.477","article-title":"Pharmacist identification of medication-related problems in the home care setting","volume":"26","author":"Vink","year":"2011","journal-title":"Consult. Pharm."},{"key":"B36","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/pgmj.71.838.466","article-title":"Prescribing in the elderly","volume":"71","author":"Walley","year":"1995","journal-title":"Postgrad. Med. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00228-017-2373-5","article-title":"Categorization and association analysis of risk factors for adverse drug events","volume":"74","author":"Zhou","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1522650\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T04:10:36Z","timestamp":1752207036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1522650\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":37,"alternative-id":["10.3389\/fphar.2025.1522650"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1522650","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"article-number":"1522650"}}